This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Cholestech Corporation. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2010
Title: Neal F. Bellet: Innovator in Cholesterol Measurement Technologies
Introduction
Neal F. Bellet, an esteemed inventor based in Walnut Creek, California, has made significant contributions to the field of medical diagnostics with a focus on cholesterol measurement technologies. With a total of three patents to his name, his innovations have enhanced the accuracy and efficiency of cholesterol assays, particularly targeting high-density lipoprotein (HDL) detection.
Latest Patents
Neal's most recent inventions include two pivotal patents. The first, titled "High-density lipoprotein assay device and method," describes an innovative device and methodology for accurately measuring HDL-associated cholesterol in blood-fluid samples. This design minimizes interference from reagents, ensuring that the HDL quantification reaction remains unaffected by other assays conducted on the same sample.
The second notable invention is the "Automated immunoassay cassette, apparatus and method." This patent outlines a unique immunoassay cassette designed for detecting analytes in liquid body-fluid samples. The cassette utilizes a movement mechanism to efficiently transfer samples between different positions, allowing for the formation of a modified sample that reacts with specific reagents, ultimately leading to the detection of analyte-dependent products.
Career Highlights
At Cholestech Corporation, Neal F. Bellet has been instrumental in advancing the company's mission of developing innovative medical technologies. His role has focused on creating solutions that improve the reliability of cholesterol testing, which is critical for managing heart health.
Collaborations
Neal has collaborated closely with fellow innovators Jeffrey Shindelman and Thomas E. Worthy. Together, they have contributed to the development of cutting-edge diagnostic devices, showcasing the importance of teamwork in pushing the boundaries of medical technology.
Conclusion
Through his innovative patents and collaborative efforts, Neal F. Bellet continues to make a significant impact in the field of medical diagnostics. His work in developing advanced HDL assays and automated immunoassay systems reflects his commitment to improving healthcare outcomes and underscores the vital role inventors play in shaping the future of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile